- News & Features
Preliminary findings link proton pump inhibitors (PPIs), drugs commonly used to reduce stomach acid and treat heartburn, to increased risk for ischemic stroke.
Researchers found that Rituximab was successful in treating a variety of autoimmune and immune-mediated cutaneous disorders.
A study found that the addition of voclosporin to standard treatment of acute lupus nephritis increased the speed of remission and overall remission rates.
As more people turn to the Internet for advice, we are reminded of the importance of being vigilant about where and how we get our information and support.
The book features more than 50 easy-to-follow recipes meant to help manage inflammation.
A new report has identified population subgroups with greater prevalence of inflammatory bowel disease.
A new study suggests that lupus low disease activity state is "a much more clinically attainable state than the stricter definitions of remission."
The findings suggest that there are distinct types of knee osteoarthritis that might require different treatments.
Researchers in Sweden have found that hospitalization for certain types of infection during childhood are associated with likelihood of a person’s later development of ankylosing spondylitis.
The field of ankylosing spondylitis (AS) has “come alive,” Atul Deodhar, MD, of Oregon Health & Science University in Portland told MedPage Today, citing promising phase 2 study results of tofacitinib (Xeljanz) in AS.